Here, we identified a novel GPx4 inhibitor, PB, a dioscin isolated from Paris formosana Hayata plants, which has been used as the main component of traditional anticancer medicine for treating lung cancer, gastric cancer and other tumours 23. This evidence concerns the gene GPX4 and lung cancer.